The effectiveness and convenience of Methotrexate (MTX) in treatment for psoriasis with the only dose 0.3mg/kg/36 hour/week at Hospital 108
- Author:
Dang Van Em
- Publication Type:Journal Article
- Keywords:
Drug, psoriasis
- MeSH:
Therapeutics;
Psoriasis;
Pharmaceutical Preparations;
Methotrexate
- From:Journal of Practical Medicine
2004;484(8):34-36
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
31 patients of psoriasis were involved in this open, uncontrolled 4 weeks study of dose MTX: 0.3mg/kg/36 hour/week, 29 subjects were men and 2 were women. Their ages ranged from 21 to 65 years old. The mean duration of psoriasis experienced was ranged from 1 to 20 years. The mean PASI score at baseline was 22.73±14.34. After treatment the PASI score was mean decreased 86.89%. MTX was effected early and every form of psoriasis.
